{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:04:13Z","timestamp":1787025853687,"version":"build-2736575974"},"reference-count":31,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.3201\/eid2703.203916","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T23:00:41Z","timestamp":1614034841000},"page":"805-812","source":"Crossref","is-referenced-by-count":22,"title":["Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan"],"prefix":"10.3201","volume":"27","author":[{"given":"Amyn A.","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel R.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Cranmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junaid F.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Amanullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir J.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmaan","family":"Keshavjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidah","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes C.","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-1","unstructured":"World Health Organization. Global tuberculosis control report 2019. 2019 [cited 2020 Sep 1]. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-report-2019"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-2","doi-asserted-by":"publisher","first-page":"2000224","DOI":"10.1183\/13993003.00224-2020","article-title":"The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis.","volume":"55","author":"Cegielski","year":"2020","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-3","first-page":"PA5278","article-title":"Adverse events in patients with MDR TB, treated by three types of the chemotherapy regimens.","volume":"54","author":"Rodina","year":"2019","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1183\/09031936.00205512","article-title":"Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination.","volume":"42","author":"Diel","year":"2013","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-5","doi-asserted-by":"publisher","first-page":"1902414","DOI":"10.1183\/13993003.02414-2019","article-title":"The case for assessing the full value of new tuberculosis vaccines.","volume":"55","author":"Gebreselassie","year":"2020","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-6","doi-asserted-by":"crossref","unstructured":"Keshavjee S, Nicholson T, Khan AJ, Ditiu L, Farmer PE, Becerra MC. Tuberculosis epidemic control: a comprehensive strategy to drive down tuberculosis. In: Friedman L, Dedicoat M, Davies PDO, editors. Clinical tuberculosis. 6th ed. Boca Raton (FL): CRC Press; 2020. p. 401\u201312.","DOI":"10.1201\/9781351249980-21"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/cid\/cit643","article-title":"Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.","volume":"58","author":"Shah","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-8","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1183\/13993003.01179-2015","article-title":"Numbers needed to treat to prevent tuberculosis.","volume":"46","author":"Matteelli","year":"2015","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-9","doi-asserted-by":"publisher","first-page":"ciaa613","DOI":"10.1093\/cid\/ciaa613","article-title":"Concordance of drug resistance profiles between persons with drug-resistant tuberculosis and their household contacts: a systematic review and meta-analysis.","author":"Chiang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-10","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. 2018 [cited 2020 Sep 1]. https:\/\/www.who.int\/tb\/publications\/2018\/latent-tuberculosis-infection"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/INF.0000000000000260","article-title":"Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.","volume":"33","author":"Adler-Shohet","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.","volume":"18","author":"Bamrah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/INF.0b013e3181783aca","article-title":"Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003.","volume":"27","author":"Feja","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up.","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-15","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/cid\/cit655","article-title":"Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.","volume":"57","author":"Seddon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-16","unstructured":"Seddon JA, Fred D, Amanullah F, Schaaf HS, Starke JR, Keshavjee S,  Post-exposure management of multidrug-resistant tuberculosis contacts: evidence-based recommendations. Policy Brief No. 1. Dubai (United Arab Emirates): Harvard Medical School Center for Global Health Delivery\u2013Dubai; 2015."},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3201\/eid2103.141313","article-title":"Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA.","volume":"21","author":"Trieu","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-18","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/cid\/cix208","article-title":"Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis.","volume":"64","author":"Marks","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-19","unstructured":"Joint United Nations Programme on HIV\/AIDS. Pakistan. 2020 [cited 2020 Sep 1]. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/pakistan"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-20","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/cid\/ciz502","article-title":"Tuberculosis preventive therapy for individuals exposed to drug-resistant tuberculosis: feasibility and safety of a community-based delivery of fluoroquinolone-containing preventive regimen.","volume":"70","author":"Malik","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-21","doi-asserted-by":"publisher","first-page":"ciaa327","DOI":"10.1093\/cid\/ciaa327","article-title":"Risk factors for adverse events in household contacts prescribed preventive treatment for drug-resistant TB exposure.","author":"Malik","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1183\/09031936.00070812","article-title":"Contact investigation for tuberculosis: a systematic review and meta-analysis.","volume":"41","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-23","doi-asserted-by":"publisher","first-page":"l5894","DOI":"10.1136\/bmj.l5894","article-title":"Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study.","volume":"367","author":"Becerra","year":"2019","journal-title":"BMJ"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0140-6736(10)61972-1","article-title":"Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.","volume":"377","author":"Becerra","year":"2011","journal-title":"Lancet"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/INF.0b013e31826f6063","article-title":"Tuberculosis in children exposed at home to multidrug-resistant tuberculosis.","volume":"32","author":"Becerra","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-26","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/cid\/ciz438","article-title":"Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team. Risk factors for tuberculosis and effect of preventive therapy among close contacts of persons with infectious tuberculosis.","volume":"70","author":"Reichler","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-27","doi-asserted-by":"publisher","first-page":"e0215322","DOI":"10.1371\/journal.pone.0215322","article-title":"Tuberculosis incidence among infected contacts detected through contact tracing of smear-positive patients.","volume":"14","author":"Martin-Sanchez","year":"2019","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-28","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1164\/rccm.201406-1159OC","article-title":"Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam.","volume":"190","author":"Sloot","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-29","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/S1473-3099(17)30447-4","article-title":"A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study.","volume":"17","author":"Saunders","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-30","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons.","volume":"1999","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.3201\/eid2703.203916-202102222300-R-2-31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5588\/ijtld.13.0593","article-title":"High tuberculosis prevalence in children exposed at home to drug-resistant tuberculosis.","volume":"18","author":"Amanullah","year":"2014","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/3\/20-3916_intro","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T12:50:48Z","timestamp":1732971048000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/27\/3\/20-3916_intro.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2703.203916","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}